Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 28, 2013
ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets.
read more
Wednesday, December 11, 2013
Celerion is pleased to announce the appointment of John Horkulak as Executive Director, Eurasian Site Operations. Mr. Horkulak will lead the efforts to further expand the company’s early phase patient capabilities in Europe and Asia.
read more
Wednesday, December 11, 2013
Marken announced today that their Singapore biological kit-building facility has now been certified to International Standards Organization (ISO) 13485 standards for the storage and distribution of medical devices.
read more
Friday, December 20, 2013
The European Medicines Agency (EMA) has now reviewed all comments received on its draft policy on publication and access to clinical trial data. While the comments received showed that there is large support for the Agency’s plans to allow access to ...
read more
Friday, December 20, 2013
Celerion is proud to announce the 80th anniversary of operations at our first facility in Lincoln, Nebraska. Celerion is at the forefront of early clinical research with corporate headquarters in Lincoln, plus seven other facilities globally ...
read more
Friday, December 20, 2013
CMC Biologics and OncoSynergy announced today that the two
companies entered into an agreement for cell-line development, process development,
analytical development and manufacturing of non-GMP material to enable early toxicology
testing and cGMP...
read more
Tuesday, January 07, 2014
Alkermes plc (NASDAQ:ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 14/032,736, entitled “Prodrugs of fumarates and their use in treating various diseases....
read more
Isarna Therapeutics GmbH announced today that it
has signed a strategic manufacturing agreement with Sanofi under which Sanofi will
manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for
Isarna, enabling Isarna to...
read more
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, and Adamas Pharmaceuticals Inc., today announced an agreement for Phase 3 clinical trials ...
read more
Tuesday, January 28, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of two senior executives to its oncology team. Asli Turkes, PhD has joined ...
read more
Tuesday, January 28, 2014
Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) West Coast conference January 28-29 in Burlingame.
read more
Thursday, February 06, 2014
Almac’s Diagnostics business unit today announced the presentation of an external validation of their ColDx signature for stage II colon cancer recurrence. Following publication of the initial validation study in the Journal of Clinical Oncology (JCO...
read more
Friday, February 07, 2014
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
(“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune
therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of
NW Bio, will ...
read more
Tuesday, February 18, 2014
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL subsidiary that provides the Perceptive MyTrials® eClinical platform and other advanced ...
read more
Tuesday, February 18, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced CEO Jamie Macdonald will participate in a panel discussion on evolving outsourcing models at ...
read more